MannKind | MNKD - Modal Pinjaman





Modal Pinjaman Perubahan Tanggal
Adma Biologics USD 69.33M 750K 2025-12
BioCryst Pharmaceuticals USD 428.67M 234.31M 2025-12
Eli Lilly USD 39.37B 1.5B 2026-03
Halozyme Therapeutics USD 2.14B 1.34B 2025-12
Insmed USD 540.96M 1.24M 2025-12
Karyopharm Therapeutics USD 278.22M 278.22M 2025-12
MacroGenics USD 70M 256K 2025-12
MannKind USD 548.44M 244.79M 2025-12
Merck USD 46.67B 77M 2026-03
Minerva Neurosciences USD 0 86.58M 2024-09
Novavax USD 246.3M 200K 2025-12
Novo Nordisk DKK 14.02B 224.49M 2025-09
Pfizer USD 60.57B 1.08B 2026-03
Sanofi EUR 13.84B 1.88B 2026-03
Xencor USD 76.48M 11.29M 2025-12